ClinicalTrials.gg

Drug

Liposomal Mitoxantrone Hydrochloride clinical trials

Also written HE071.

A product of Mitoxantrone; its studies count on that page too.

studies test it
35
open now
11
in phase 3
1
first study started
2011

Keep track of what changes. Save the Liposomal Mitoxantrone Hydrochloride studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

35 studies that test it; most in 2021 (9)

Studies that test Liposomal Mitoxantrone Hydrochloride, by start year
YearStudies
20111
20131
20151
20161
20181
20191
20202
20219
20226
20235
20244
20252
20261

By phase

A phase 1/2 study counts in both.

Phase 1
17
Phase 2
18
Phase 3
1
No phase
5

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 23 · Other 12

CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (20) · The First Affiliated Hospital with Nanjing Medical University (3) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (2) · Sun Yat-sen University (1) · Sun Yat-Sen University Cancer Center (1) · Shanghai JMT-Bio Inc. (1) · First Affiliated Hospital Xi'an Jiaotong University (1) · The First Hospital of Jilin University (1)

Often tested with

Tested in the same studies.

Vincristine (5) · Rituximab (4) · Etoposide (3) · Cyclophosphamide (3) · Irinotecan (2) · Ifosfamide (2) · Venetoclax (2) · Prednisone (2)

Studies

Open first, then newest update. How each study uses Liposomal Mitoxantrone Hydrochloride is read from its arms, and is right about nine times in ten.

Testing it · 35

See all 35 studies that test Liposomal Mitoxantrone Hydrochloride →

Given in every arm · 17 — Liposomal Mitoxantrone Hydrochloride is usual care beside what is tested